As of 2024-12-12, the Relative Valuation of HAVN Life Sciences Inc (HAVN.CN) is (1.33) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 CAD, the upside of HAVN Life Sciences Inc based on Relative Valuation is -4532.7%.
The range of the Relative Valuation is (1.25) - (1.32) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.3x - 3.4x | 2.8x |
| Forward P/E multiples | 1.6x - 2.4x | 2.0x |
| Fair Price | (1.25) - (1.32) | (1.33) |
| Upside | -4267.6% - -4487.0% | -4532.7% |
| Date | P/E |